An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

An Integrative Approach to Sarcoidosis and Mixed Connective Tissue Disease - Deanna Windham, DO (2021 Conference) (LDN, low dose naltrexone)

This presentation is about sarcoidosis and mixed connective tissue disease, which are being considered together, because they are both autoimmune diseases. She discusses how different systems work together to cause a person to be susceptible to autoimmune disease, and the major systems that cause the epigenetic changes leading to autoimmune disease. Case studies are presented. Various treatments are discussed, including low dose naltrexone (LDN).

While it can seem complicated, if you determine the triggers and find ways of evaluating and treating each one, you will be able to improve patient care, patient outcomes, and improve their lives and healthy longevity.

KEYWORDS: sarcoidosis, mixed connective tissue disease, autoimmune, epigenetic disease, hormone, immune, cytokines, nutrition, dysbiosis, environmental toxins, immune modulators, low dose naltrexone (LDN)

This is a summary of the presentation. Click on the video for full information.